SK intends to create API industry leader
Private investment firm SK Capital plans to transform the active pharmaceutical ingredients (APIs) business that it has just acquired from Perrigo for US$110 million into “an industry leader”.
Private investment firm SK Capital plans to transform the active pharmaceutical ingredients (APIs) business that it has just acquired from Perrigo for US$110 million into “an industry leader”.